Effects of nicotine and a cannabinoid receptor agonist on negative contrast: Distinction between anxiety and disappointment?

Psychopharmacology

Volumn 177, Issue 1-2, 2004, Pages 93-99

  Genn, Rachel F ^a   Tucci, S ^a   Parikh, S ^a   File, S E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; CP 55,940; Disappointment; Nicotine; Successive negative contrast

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CHLORDIAZEPOXIDE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EMOTION; LOCOMOTION; LOW DRUG DOSE; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SOCIAL INTERACTION;

ANIMALS; ANXIETY; CANNABINOIDS; CYCLOHEXANOLS; EMOTIONS; INTERPERSONAL RELATIONS; MALE; MAZE LEARNING; NICOTINE; RATS; RECEPTORS, CANNABINOID;

EID: 12144272470     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1932-5     Document Type: Article

References (49)

1. Arévalo C, Miguel R, Hermandez-Tristian R (2001) Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70:123-131
2. Becker HC (1986) Comparison of the effects of the benzodiazepine midazolam and three serotonin antagonists on a consummatory conflict paradigm. Pharmacol Biochem Behav 24:1057-1064
3. Becker H, Flaherty CF (1982) Influence of ethanol on contrast in consummatory behaviour. Psychopharmacology 77:253-258
4. Becker H, Flaherty CF (1983) Chlordiazepoxide and ethanol additively reduce gustatory negative contrast. Psychopharmacology 80:35-37
5. Becker HC, Jarvis M, Wagner G, Flaherty CF (1984) Medial and lateral amygdala lesions differentially influence contrast with sucrose solutions. Physiol Behav 33:707-712
6. Cheeta S, Irvine EE, Kenny PJ, File SE (2001) The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology 155:78-85
7. Dunham PJ (1968) Contrasted conditions of reinforcement: a selective critique. Psychol Bull 69:295-315
8. Dunn AJ, File SE (1987) Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav 21:193-202
9. Fernandes C, File SE (1996) The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav 54:31-40
10. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth 2:219-238
11. File SE (1992) Behavioural detection of anxiolytic action. In: Elliot JM, Heal DJ, Marsden CA (eds) Experimental approaches to anxiety and depression. Wiley, London, pp 25-44
12. File SE, Andrews N (1991) Low but not high doses of buspirone reduce anxiogenic effects of diazepam withdrawal. Psychopharmacology 105:578-582
13. File SE, Hyde JR (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24
14. File SE, Seth P (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53
15. File SE, Baldwin HA, Aranko K (1987) Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance. Brain Res Bull 19:607-610
16. File SE, Zangrossi H Jr, Sanders FL, Mabbutt PS (1993) Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor. Physiol Behav 54:1109-1111
17. File SE, Kenny PJ, Ouagazzal AM (1998) Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 112:1423-1429
18. Flaherty CF (1991) Effects of anxiolytics and antidepressants on extinction and negative contrast. In: File SE (ed) Psychopharmacology of anxiolytics and antidepressants. Pergamon, New York, p 231
19. Flaherty CF (1996) Successive contrast: psychopharmacology and neurobiology. In: Flaherty CF (ed) Incentive relatively (problems in behavioural sciences). Cambridge University, Cambridge, pp 54-80
20. Flaherty CF, Driscoll CD (1980) Amobarbitol sodium reduces successive gustatory contrast. Psychopharmacology 69:161-162
21. Flaherty CF, Meinrath A (1979) Influence of scopolamine on sucrose intake under absolute and relative test conditions. Physiol Psychol 7:412-418
22. Flaherty CF, Lombardi BR, Wrightson J, Deptula D (1980) Conditions under which chlordiazepoxide influences gustatory contrast. Psychopharmacology 67:269-277
23. Flaherty CF, Becker HC, Pohorecky LA (1985) Correlation of corticosterone elevation and negative contrast varies as a function of post-shift day. Anim Learn Behav 13:309-314
24. Flaherty CF, Grigson PS, Rowan GA (1986) Chlordiazepoxide and the determinants of negative contrast. Anim Learn Behav 3:315-321
25. Flaherty CF, Grigson PS, Lind S (1990a) Chlordiazepoxide and the moderation of the initial response to reward reduction. Q J Exp Psychol B 42:87-105
26. Flaherty CF, Grigson PS, Demetrikopoulos MK, Weaver MS, Krauss KL, Rowan GA (1990b) Effects of serotonergic drugs on negative contrast in consummately behavior. Pharmacol Biochem Behav 36:799-806
27. Flaherty CF, Greenwood A, Martin J, Leszczuk M (1998) Relationship of negative contrast to animal models of fear and anxiety. Anim Learn Behav 26:397-407
28. Genn RF, Barr AM, Phillips AG (2002) Effect of amisulpride on consummatory negative contrast. Behav Pharmacol 13:1-6
29. Genn RF, Tucci, S, Thomas A, Edwards JE, File SE (2003a) Age-associated sex differences in response to food deprivation in two animal tests of anxiety. Neurosci Biobehav Rev 27:155-161
30. Genn RF, Tucci S, Marco E, Viveros MP, File SE (2003b) Anxiolytic and anxiogenic effects of the cannabinoid agonist CP 55,940 in animal tests of anxiety. J Psychopharmacol 17: B11
31. Genn RF, Tucci, Parikh S, File SE (2003c) A cannabinoid helps dissociate between anxiety and reward reduction in the rat. J Psychopharmacol 17:B12
32. Glass M, Dragunow M, Faull R (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299-318
33. Grigson PS, Flaherty CF (1990) Cyproheptadine prevents the initial occurrence of successive negative contrast. Pharmacol Biochem Behav 40:433-442
34. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936
35. Higgs S, Williams CM, Kirkham TC (2003) Cannabinoid influences on palatability: micro structural analysis of sucrose drinking after delta-9-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716A. Psychopharmacology 165:370-377
36. Irvine EE, Cheeta S, File SE (1999) Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 10:691-697
37. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518
38. Lombardi BR, Flaherty CF (1978) Apparent disinhibition of successive but not of simultaneous negative contrast. Anim Learn Behav 6:30-42
39. Marin S, Marco E, Biscaia M, Fernandez B, Rubio M, Guaza C, Schmidhammer H, Viveros MP (2003) Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. Pharmacol Biochem Behav 74:649-656
40. Marsicano G, Wotjak CT, Azad SC, Bisognol T, Rammes G, Casio MG, Hernano H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
41. Mitchell C, Flaherty C (1998) Temporal dynamics of corticosterone elevation in successive negative contrast. Physiol Behav 64:287-292
42. Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253:1002-1009
43. Pecoraro NC, Timberlake WD, Tinsley M (1999) Incentive down-shifts evoke search repertoires in rats. J Exp Psychol 25:153-167
44. Fellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167
45. Rowan GA, Flaherty CF (1987) Effects of morphine in the consummatory contrast paradigm. Psychopharmacology 93:51-58
46. Tucci S, Cheeta S, Genn RF, Seth P, File SE (2002) Anxiety conditioned to nicotine in the elevated plus-maze is time dependent. Behav Pharmacol 13:615-620
47. Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143:315-317
48. Zangrossi H Jr, File SE (1992) Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol Biochem Behav 43:1195-1200
49. Zangrossi H Jr, File SE (1994) Habituation and generalization of phobic responses to cat odor. Brain Res Bull 33:189-194